BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3179959)

  • 1. The clinical spectrum of pure Bence Jones proteinuria. A study of 66 patients.
    Pascali E; Pezzoli A
    Cancer; 1988 Dec; 62(11):2408-15. PubMed ID: 3179959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Idiopathic Bence-Jones proteinuria": a new characterization of an old entity.
    Mian M; Franz I; Wasle I; Herold M; Griesmacher A; Prokop W; Cortelazzo S; Gastl G; Willenbacher W; Gunsilius E; Fiegl M
    Ann Hematol; 2013 Sep; 92(9):1263-70. PubMed ID: 23580149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical significance of pure Bence Jones proteinuria at low concentration.
    Pezzoli A; Pascali E
    Am J Clin Pathol; 1989 Apr; 91(4):473-5. PubMed ID: 2929504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum and urine monoclonal immunoglobulins in malignant non-Hodgkin's lymphoma.
    Pascali E; Pezzoli A
    Acta Haematol; 1986; 75(4):193-8. PubMed ID: 3096049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal Bence Jones proteinuria in chronic lymphocytic leukaemia.
    Pezzoli A; Pascali E
    Scand J Haematol; 1986 Jan; 36(1):18-24. PubMed ID: 3952462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The outcome of idiopathic Bence Jones proteinuria.
    Kanoh T; Ohnaka T; Uchino H; Fujii H
    Tohoku J Exp Med; 1987 Jan; 151(1):121-6. PubMed ID: 3107161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal free light chains in urine and their significance in clinical diagnostics: are they really tumor markers?
    Végh Z; Ottó S; Eckhardt S
    J Clin Lab Anal; 1990; 4(6):443-8. PubMed ID: 2283564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical significance of Bence Jones proteinuria.
    Perry MC; Kyle RA
    Mayo Clin Proc; 1975 May; 50(5):234-8. PubMed ID: 1127990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Idiopathic" Bence Jones proteinuria: long-term follow-up in seven patients.
    Kyle RA; Greipp PR
    N Engl J Med; 1982 Mar; 306(10):564-7. PubMed ID: 7057813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteinuria in multiple myeloma and related diseases.
    Ganeval D; Lacour B; Chopin N; Grünfeld JP
    Am J Nephrol; 1990; 10 Suppl 1():58-62. PubMed ID: 2124083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Twenty-four-hour Bence-Jones protein determinations: can we ensure accuracy?
    Kaplan JS; Horowitz GL
    Arch Pathol Lab Med; 2011 Aug; 135(8):1048-51. PubMed ID: 21809998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors for malignant transformation in monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
    Cesana C; Klersy C; Barbarano L; Nosari AM; Crugnola M; Pungolino E; Gargantini L; Granata S; Valentini M; Morra E
    J Clin Oncol; 2002 Mar; 20(6):1625-34. PubMed ID: 11896113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary gamma-glutamyl transferase-to-creatinine ratio as an indicator of tubular function in Bence Jones proteinuria.
    Yesil EE; Paker N; Yesil A; Kayatas K; Laleli Y; Ari E
    Ren Fail; 2014 Apr; 36(3):390-2. PubMed ID: 24392854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunocytoma, cancer and other associations of monoclonal gammopathy: a review of 224 cases.
    Colls BM; Lorier MA
    N Z Med J; 1975 Oct; 82(549):221-6. PubMed ID: 1059967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The significance of analysis and detection of Bence Jones protein in the urine in clinical laboratory diagnosis].
    Végh Z; Ottó S
    Orv Hetil; 1989 Aug; 130(35):1871-5. PubMed ID: 2507996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ratio of urinary free immunoglobulin light chain kappa to lambda in the diagnosis of Bence Jones proteinuria.
    Nakano T; Nagata A; Takahashi H
    Clin Chem Lab Med; 2004 Apr; 42(4):429-34. PubMed ID: 15147154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immuno-isotachophoretic determination of monoclonal immunoglobulin light chains produced by neoplastic B-cells: use in diagnosis, monitoring and detection of residual disease.
    Abelev GI; Karamova ER; Bragina EG; Andreeva NE; Kruglova GV
    Int J Cancer; 1990 Sep; 46(3):351-5. PubMed ID: 2118484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical spectrum of light chain myeloma. A study of 35 patients with special reference to the occurrence of amyloidosis.
    Stone MJ; Frendel EP
    Am J Med; 1975 May; 58(5):601-19. PubMed ID: 1130419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current status regarding detection of monoclonal component in Japan].
    Yamada T
    Rinsho Byori; 2010 Apr; 58(4):397-400. PubMed ID: 20496769
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.